Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of sanglifehrin macrocyclic analogues as anticancer compounds

Use of sanglifehrin macrocyclic analogues as anticancer compounds

US Patent 10857150 · Granted Dec 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cell-permeable succinate compounds2025
Cell-permeable succinate compounds2025
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2024
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2024
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2024
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2024
Methods for producing hybrid polyketide synthase genes and polyketides2023
Immunorhelin compounds for intracellular infections2023
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2023
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2023
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2023
Succinate prodrug, compositions containing the succinate prodrug and uses thereo2023